Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Clinical trial NCT06968195 · SUSPENDED

Trial details

NCT number: NCT06968195
Sponsor: Roswell Park Cancer Institute
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma Metastatic Hepatocellular Carcinoma Recurrent Hepatocellular Carcinoma Refractory Hepatocellular Carcinoma Stage III Hepatocellular Carcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8

Start date: 2026-07-15
Primary completion: 2028-05-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.